These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

670 related items for PubMed ID: 17681686

  • 1. Human serum albumin (HSA) nanoparticles: reproducibility of preparation process and kinetics of enzymatic degradation.
    Langer K, Anhorn MG, Steinhauser I, Dreis S, Celebi D, Schrickel N, Faust S, Vogel V.
    Int J Pharm; 2008 Jan 22; 347(1-2):109-17. PubMed ID: 17681686
    [Abstract] [Full Text] [Related]

  • 2. A toolbox for the upscaling of ethanolic human serum albumin (HSA) desolvation.
    Wacker M, Zensi A, Kufleitner J, Ruff A, Schütz J, Stockburger T, Marstaller T, Vogel V.
    Int J Pharm; 2011 Jul 29; 414(1-2):225-32. PubMed ID: 21571055
    [Abstract] [Full Text] [Related]

  • 3. Preparation, characterisation and maintenance of drug efficacy of doxorubicin-loaded human serum albumin (HSA) nanoparticles.
    Dreis S, Rothweiler F, Michaelis M, Cinatl J, Kreuter J, Langer K.
    Int J Pharm; 2007 Aug 16; 341(1-2):207-14. PubMed ID: 17478065
    [Abstract] [Full Text] [Related]

  • 4. Preparation of sub-100 nm human serum albumin nanospheres using a pH-coacervation method.
    Lin W, Coombes AG, Davies MC, Davis SS, Illum L.
    J Drug Target; 1993 Aug 16; 1(3):237-43. PubMed ID: 8069565
    [Abstract] [Full Text] [Related]

  • 5. Tumour cell delivery of antisense oligonuclceotides by human serum albumin nanoparticles.
    Wartlick H, Spänkuch-Schmitt B, Strebhardt K, Kreuter J, Langer K.
    J Control Release; 2004 May 18; 96(3):483-95. PubMed ID: 15120904
    [Abstract] [Full Text] [Related]

  • 6. Photosensitizer loaded HSA nanoparticles. I: Preparation and photophysical properties.
    Wacker M, Chen K, Preuss A, Possemeyer K, Roeder B, Langer K.
    Int J Pharm; 2010 Jun 30; 393(1-2):253-62. PubMed ID: 20417701
    [Abstract] [Full Text] [Related]

  • 7. Protein adsorption from flowing solutions on pure and maleic acid copolymer modified glass particles.
    Klose T, Welzel PB, Werner C.
    Colloids Surf B Biointerfaces; 2006 Aug 01; 51(1):1-9. PubMed ID: 16797943
    [Abstract] [Full Text] [Related]

  • 8. Adsorption of obidoxime onto human serum albumin nanoparticles: drug loading, particle size and drug release.
    Kufleitner J, Wagner S, Worek F, von Briesen H, Kreuter J.
    J Microencapsul; 2010 Aug 01; 27(6):506-13. PubMed ID: 20214419
    [Abstract] [Full Text] [Related]

  • 9. Optimization of the preparation process for human serum albumin (HSA) nanoparticles.
    Langer K, Balthasar S, Vogel V, Dinauer N, von Briesen H, Schubert D.
    Int J Pharm; 2003 May 12; 257(1-2):169-80. PubMed ID: 12711172
    [Abstract] [Full Text] [Related]

  • 10. Interaction of folate-conjugated human serum albumin (HSA) nanoparticles with tumour cells.
    Ulbrich K, Michaelis M, Rothweiler F, Knobloch T, Sithisarn P, Cinatl J, Kreuter J.
    Int J Pharm; 2011 Mar 15; 406(1-2):128-34. PubMed ID: 21185364
    [Abstract] [Full Text] [Related]

  • 11. Albumin nanoparticles with predictable size by desolvation procedure.
    Storp Bv, Engel A, Boeker A, Ploeger M, Langer K.
    J Microencapsul; 2012 Mar 15; 29(2):138-46. PubMed ID: 22329480
    [Abstract] [Full Text] [Related]

  • 12. Preparation and characterization of water-soluble albumin-bound curcumin nanoparticles with improved antitumor activity.
    Kim TH, Jiang HH, Youn YS, Park CW, Tak KK, Lee S, Kim H, Jon S, Chen X, Lee KC.
    Int J Pharm; 2011 Jan 17; 403(1-2):285-91. PubMed ID: 21035530
    [Abstract] [Full Text] [Related]

  • 13. Incorporation of obidoxime into human serum albumin nanoparticles: optimisation of preparation parameters for the development of a stable formulation.
    Kufleitner J, Worek F, Kreuter J.
    J Microencapsul; 2010 Jan 17; 27(7):594-601. PubMed ID: 20923399
    [Abstract] [Full Text] [Related]

  • 14. Freeze drying of human serum albumin (HSA) nanoparticles with different excipients.
    Anhorn MG, Mahler HC, Langer K.
    Int J Pharm; 2008 Nov 03; 363(1-2):162-9. PubMed ID: 18672043
    [Abstract] [Full Text] [Related]

  • 15. Preparation and characterization of sodium ferulate entrapped bovine serum albumin nanoparticles for liver targeting.
    Li FQ, Su H, Wang J, Liu JY, Zhu QG, Fei YB, Pan YH, Hu JH.
    Int J Pharm; 2008 Feb 12; 349(1-2):274-82. PubMed ID: 17870261
    [Abstract] [Full Text] [Related]

  • 16. Drug release study of large hollow nanoparticulate aggregates carrier particles for pulmonary delivery.
    Hadinoto K, Zhu K, Tan RB.
    Int J Pharm; 2007 Aug 16; 341(1-2):195-206. PubMed ID: 17467934
    [Abstract] [Full Text] [Related]

  • 17. Monodisperse chitosan nanoparticles for mucosal drug delivery.
    Zhang H, Oh M, Allen C, Kumacheva E.
    Biomacromolecules; 2004 Aug 16; 5(6):2461-8. PubMed ID: 15530064
    [Abstract] [Full Text] [Related]

  • 18. Formulation of an intermediate product from human serum albumin for the production of a solid dosage form.
    Kristó K, Bajdik J, Eros I, Dékány I, Pallai Z, Pintye-Hódi K.
    Eur J Pharm Biopharm; 2008 Mar 16; 68(3):741-6. PubMed ID: 17870448
    [Abstract] [Full Text] [Related]

  • 19. Preparation of Bovine Serum Albumin (BSA) nanoparticles by desolvation using a membrane contactor: a new tool for large scale production.
    Yedomon B, Fessi H, Charcosset C.
    Eur J Pharm Biopharm; 2013 Nov 16; 85(3 Pt A):398-405. PubMed ID: 23811438
    [Abstract] [Full Text] [Related]

  • 20. Design and evaluation of itraconazole loaded solid lipid nanoparticulate system for improving the antifungal therapy.
    Mukherjee S, Ray S, Thakur RS.
    Pak J Pharm Sci; 2009 Apr 16; 22(2):131-8. PubMed ID: 19339221
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.